These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 38701000)

  • 21. Conflicting and changing breast cancer screening recommendations: survey study of a national sample of ob-gyns after the release of the 2009 USPSTF guidelines.
    Anderson BL; Pearlman M; Griffin J; Schulkin J
    J Healthc Qual; 2013; 35(4):25-35. PubMed ID: 23590634
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sorting through the arguments on breast screening.
    Marmot MG
    JAMA; 2013 Jun; 309(24):2553-4. PubMed ID: 23722915
    [No Abstract]   [Full Text] [Related]  

  • 23. The public's response to the U.S. Preventive Services Task Force's 2009 recommendations on mammography screening.
    Squiers LB; Holden DJ; Dolina SE; Kim AE; Bann CM; Renaud JM
    Am J Prev Med; 2011 May; 40(5):497-504. PubMed ID: 21496748
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of the controversial US Preventive Services Task Force recommendations on the use of screening mammography.
    Sharpe RE; Levin DC; Parker L; Rao VM
    J Am Coll Radiol; 2013 Jan; 10(1):21-4. PubMed ID: 23290669
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Change in Breast Cancer Screening Intervals Since the 2009 USPSTF Guideline.
    Wernli KJ; Arao RF; Hubbard RA; Sprague BL; Alford-Teaster J; Haas JS; Henderson L; Hill D; Lee CI; Tosteson ANA; Onega T
    J Womens Health (Larchmt); 2017 Aug; 26(8):820-827. PubMed ID: 28177856
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mammography rates after the 2009 revision to the United States Preventive Services Task Force breast cancer screening recommendation.
    Qin X; Tangka FK; Guy GP; Howard DH
    Cancer Causes Control; 2017 Jan; 28(1):41-48. PubMed ID: 28025762
    [TBL] [Abstract][Full Text] [Related]  

  • 27. US panel reaffirms controversial 2009 mammography recommendations.
    McCarthy M
    BMJ; 2015 Apr; 350():h2174. PubMed ID: 25902838
    [No Abstract]   [Full Text] [Related]  

  • 28. Association of Patient Age With Outcomes of Current-Era, Large-Scale Screening Mammography: Analysis of Data From the National Mammography Database.
    Lee CS; Sengupta D; Bhargavan-Chatfield M; Sickles EA; Burnside ES; Zuley ML
    JAMA Oncol; 2017 Aug; 3(8):1134-1136. PubMed ID: 28426842
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Breast Cancer Screening: Women's Attitudes and Beliefs in Light of Updated United States Preventive Services Task Force and American Cancer Society Guidelines.
    Mehta JM; MacLaughlin KL; Millstine DM; Faubion SS; Wallace MR; Shah AA; Fields HE; Ruddy BE; Bryan MJ; Patel B; Temkit MH; Buras MR; Golafshar MA; Kling JM
    J Womens Health (Larchmt); 2019 Mar; 28(3):302-313. PubMed ID: 30204537
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The 2009 breast cancer screening recommendations of the US Preventive Services Task Force.
    Woolf SH
    JAMA; 2010 Jan; 303(2):162-3. PubMed ID: 20068210
    [No Abstract]   [Full Text] [Related]  

  • 31. Lessons from the mammography wars.
    Quanstrum KH; Hayward RA
    N Engl J Med; 2010 Sep; 363(11):1076-9. PubMed ID: 20825322
    [No Abstract]   [Full Text] [Related]  

  • 32. Breast cancer screening: conflicting guidelines and medicolegal risk.
    Kachalia A; Mello MM
    JAMA; 2013 Jun; 309(24):2555-6. PubMed ID: 23722969
    [No Abstract]   [Full Text] [Related]  

  • 33. Lack of Impact of the 2009 USPSTF Guidelines on Rates of Mammography Screening.
    Brown C; Nevola A; Martin BC
    J Womens Health (Larchmt); 2018 Jul; 27(7):875-884. PubMed ID: 29583065
    [TBL] [Abstract][Full Text] [Related]  

  • 34. "Do unto others as you would have them do unto you": breast imagers' perspectives regarding screening mammography for others and for themselves--do they practice what they preach?
    Lee J; Gordon PB; Whitman GJ
    AJR Am J Roentgenol; 2015 Jun; 204(6):1336-44. PubMed ID: 26001246
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Effect of the Controversial US Preventive Services Task Force Recommendations on the Use of Screening Mammography.
    Sharpe RE; Levin DC; Parker L; Rao VM
    J Am Coll Radiol; 2016 Nov; 13(11S):e58-e61. PubMed ID: 27814825
    [TBL] [Abstract][Full Text] [Related]  

  • 36. What Do the European Breast Cancer Screening Guidelines Portend for U.S. Practice?
    Elmore JG; Lee CI
    Ann Intern Med; 2020 Jan; 172(1):65-66. PubMed ID: 31766056
    [No Abstract]   [Full Text] [Related]  

  • 37. Patient preferences in breast cancer screening: lessons to be learned from the US Preventive Services Task Force.
    Sadigh G; Kelly AM; Fagerlin A; Carlos RC
    Acad Radiol; 2011 Nov; 18(11):1333-6. PubMed ID: 21835650
    [No Abstract]   [Full Text] [Related]  

  • 38. Current controversies in breast cancer screening.
    Shepardson LB; Dean L
    Semin Oncol; 2020 Aug; 47(4):177-181. PubMed ID: 32513421
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Behavioral consequences of conflict-oriented health news coverage: the 2009 mammography guideline controversy and online information seeking.
    Weeks BE; Friedenberg LM; Southwell BG; Slater JS
    Health Commun; 2012; 27(2):158-66. PubMed ID: 21823950
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Consensus conference: should breast cancer screening be tailored to selected risk factors?].
    Bonelli L; Poirè I
    Epidemiol Prev; 2013; 37(4-5):328-35. PubMed ID: 24293499
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.